NCT06436989

Brief Summary

Studies have shown that disposable plastic tableware will cause harm to human health after heat exposure, which is closely related to the rapid development of modern society and economy and the accelerated pace of life. Most of the existing studies focused on the characterization of micro-nano plastic particles and organic pollutants such as bisphenol A and polycyclic aromatic hydrocarbons produced after thermal exposure of disposable plastic tableware, but did not pay sufficient attention to the potential relationship with individual health effects. In addition; Sporadic animal tests and molecular tests have verified the health hazards of disposable plastic tableware leaching solution. Based on the previous research results, we believe that the leaching solution of disposable plastic tableware at high temperature environment will disturb the intestinal flora structure, affect the intestinal metabolic profile, and produce adverse health outcomes for human intestinal health. This study intends to recruit healthy school students as research objects, and collect urine and stool samples of test subjects, in order to explore the effects of high-temperature leaching solution of disposable plastic tableware on intestinal health of adults.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Mar 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 24, 2024

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

May 6, 2024

Completed
25 days until next milestone

First Posted

Study publicly available on registry

May 31, 2024

Completed
13 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 13, 2024

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 20, 2024

Completed
Last Updated

May 31, 2024

Status Verified

May 1, 2024

Enrollment Period

3 months

First QC Date

May 6, 2024

Last Update Submit

May 29, 2024

Conditions

Outcome Measures

Primary Outcomes (2)

  • Forced Vital Capacity(FVC)

    We plan to measure forced vital capacity (FVC) of lung function.

    Baseline and after 4 weeks plants exposure in first stage, and after washout period, baseline and after 4weeks plants exposure in second stage

  • Blood Pressure(BP)

    We plan to measure systolic blood pressure (SBP) and diastolic blood pressure (DBP)

    Baseline and after 4 weeks plants exposure in first stage, and after washout period, baseline and after 4weeks plants exposure in second stage.

Secondary Outcomes (1)

  • Heart Rate Variability(HRV)

    Baseline and after 4 weeks plants exposure in first stage, and after washout period, baseline and after 4weeks plants exposure in second stage.

Other Outcomes (1)

  • C-reactive protein(CRP)

    Baseline and after 4 weeks plants exposure in first stage, and after washout period, baseline and after 4weeks plants exposure in second stage.

Study Arms (2)

hot water

EXPERIMENTAL

300ml pure water cooled to room temperature in a kettle.

Other: hot purified water

normal temperature water

PLACEBO COMPARATOR

300 ml pure water without any treatment

Other: hot purified water

Interventions

Hot purified water,drink once a workday,almost 360mL.Buy from regular channels.

hot waternormal temperature water

Eligibility Criteria

Age18 Years - 35 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Healthy college students aged 18 to 35;
  • Subjects can receive the intervention in this study.

You may not qualify if:

  • Have been diagnosed with diabetes, ulcerative colitis, Crohn's disease, or an infectious disease;
  • Chemotherapy, radiation or surgery 3-6 months prior to sampling;
  • Abnormal bowel movements one week before sampling;
  • I was menstruating at the time of sampling;
  • In the past three months, the sample has taken probiotics and other related health products and dietary supplements.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Zhejiang Chinese Medicine University

Hangzhou, Zhejiang, 310000, China

Location

MeSH Terms

Conditions

Inflammation

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
OTHER
Intervention Model
CROSSOVER
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Associate professor

Study Record Dates

First Submitted

May 6, 2024

First Posted

May 31, 2024

Study Start

March 24, 2024

Primary Completion

June 13, 2024

Study Completion

December 20, 2024

Last Updated

May 31, 2024

Record last verified: 2024-05

Locations